Table 4.
Test | MSr group during relapse (MSr1) (N = 60) | MSr group 1 month after relapse (MSr2) (N = 60) |
MSr group 3 months after relapse (MSr3) (N = 60) |
ANOVA | Post hoc |
---|---|---|---|---|---|
SDMT | 40.18 ± 11.42 | 46.20 ± 12.28 | 46.62 ± 10.96 | F = 43.08; p < 0.001* |
MSr1 < MSr2,MSr3 MSr2 = MSr3 |
BVMT-R (0–36) |
22.57 ± 6.07 | 26.30 ± 4.56 | 26.93 ± 4.62 | F = 34.73; p < 0.001* |
MSr1 < MSr2,MSr3 MSr2 = MSr3 |
CVLT-II (0–80) |
52.02 ± 9.61 | 58.45 ± 8.36 | 60.57 ± 9.59 | F = 65.87; p < 0.001 |
MSr1 < MSr2 < MSr3 |
CVLT-II delayed recall (0–16) |
12.23 ± 2.66 | 13.72 ± 2.22 | 13.98 ± 2.04 | F = 33.84; p < 0.001* |
MSr1 < MSr2,MSr3 MSr2 = MSr3 |
MSr1 – relapsing MS patients during relapse, MSr2 – relapsing MS patients one month after relapse, MSr3 – relapsing MS patients three months after relapse, SDMT – Symbol Digit Modalities Test, BVMT-R – Brief Visuospatial Memory Test-Revised, CVLT-II – California verbal learning test, II ed.
*Repeated-measures analysis of variance (rmANOVA) with Greenhouse-Geisser correction for violation of sphericity was used.